• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Talkspace Announces Third Quarter 2023 Results

    11/2/23 8:00:00 AM ET
    $TALK
    Medical/Nursing Services
    Health Care
    Get the next $TALK alert in real time by email

    B2B payor revenue grew 132% year-over-year

    3Q 2023 Operating expenses of $24.0 million, down 30% year-over-year

    Reduced Net Loss to $4.4 million and Adjusted EBITDA1 loss to $2.8 million, an improvement of 75% and 82% year-over-year, respectively

    NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Talkspace, Inc. (NASDAQ:TALK), today reported third quarter 2023 financial results.

      Three Months Nine Months
    Period Ended September 30, 2023 (Unaudited) Results Variance from

    Prior Year %
     Results Variance from

    Prior Year %
    (In thousands unless otherwise noted)        
    Number of B2B eligible lives at period end (in millions) 113 31% 113 31%
    Number of completed B2B sessions during the period 228.6 105% 600.8 102%
    Number of Consumer active members at period end 13.3 (26)% 13.3 (26)%
             
    Total revenue $38,646 32% $107,627 20%
    Gross profit $18,849 29% $53,409 21%
    Gross margin % 48.8%   49.6%  
    Operating expenses $24,028 (30)% $74,035 (30)%
    Net loss $(4,414) 75% $(17,876) 71%
    Adjusted EBITDA1 $(2,800) 82% $(13,223) 74%
    Cash and cash equivalents at period end $125,332 — $125,332 —
     
    (1) Adjusted EBITDA is a non-GAAP financial measure. For a definition of the measure and a reconciliation to the most directly comparable GAAP measure, see "Reconciliation of Non-GAAP Results to GAAP Results."



    Dr. Jon Cohen, CEO of Talkspace, said, "The strong momentum in our payor business continues, driven by increasing demand for high-quality in-network benefits and enhanced engagement across our covered population. We grew our clinical network to support our current and future growth, while driving further gains in access and quality metrics and improving network productivity. These enhancements and our relentless focus on innovation will drive our growth as we continue to expand in existing and new verticals."

    Jennifer Fulk, CFO of Talkspace, said, "We experienced strong sessions growth in the quarter, while we continue to achieve further efficiencies in collections, traffic conversion and treasury operations. Our leverageable cost base has allowed us to make further progress towards break-even, while enhancing the size and quality of our clinical operations."

    Third Quarter 2023 Key Performance Metrics

    • Revenue increased 32% over the prior-year period to $38.6 million, driven by a 79% year-over-year increase in the B2B revenue categories, partially offset by a 32% year-over-year consumer revenue decline.
    • Gross profit increased 29% over the prior-year period to $18.8 million, and gross margin declined to 48.8% from 49.8% year-over-year, driven by a shift in revenue mix towards payor.
    • Operating expenses were $24.0 million, down 30% year-over-year, driven by a reduction across all of our operating cost categories.
    • Net loss was $(4.4) million, an improvement from $(18.0) million net loss in the third quarter of 2022, primarily driven by lower operating expenses and an increase in revenues.

    Financial Outlook

    The following guidance is based on current market conditions and expectations and what the Company knows today.

    For the Fiscal Year 2023, Talkspace expects:

    • Revenue to be approximately $146 million, improved from our previous expectations of $137 million to $142 million.
    • Adjusted EBITDA loss to be in the range of $(16) million to $(17) million, narrowed from our previous expectations of $(16) million to $(19) million.

    The Company expects to reach break-even Adjusted EBITDA by the end of the first quarter of 2024, with a cash balance of approximately $120 million.

    Conference Call, Presentation Slides, and Webcast Details

    The conference call will be available via audio webcast at investors.talkspace.com and can also be accessed by dialing (888) 330-2391 for U.S. participants, or +1 (240) 789-2702 for international participants, and referencing participant code 2348878. A replay will be available shortly after the call's completion and remain available for approximately 90 days.

    About Talkspace

    Talkspace (NASDAQ:TALK) is a leading virtual behavioral healthcare company committed to helping people lead healthier, happier lives through access to high-quality mental healthcare. At Talkspace, we believe that mental healthcare is core to overall healthcare and should be available to everyone.

    Talkspace pioneered the ability to text with a licensed therapist from anywhere and now offers a comprehensive suite of mental health services from self-guided products to individual and couples therapy, in addition to psychiatric treatment and medication management. With Talkspace's core psychotherapy offering, members are matched with one of thousands of licensed providers across all 50 states and can choose from a variety of subscription plans including live video, text or audio chat sessions and/or asynchronous text messaging.

    All care offered at Talkspace is delivered through an easy-to-use, fully-encrypted web and mobile platform that meets HIPAA, federal, and state regulatory requirements. Talkspace covers approximately 113 million lives as of September 30, 2023, through our partnerships with employers, health plans, and paid benefits programs.

    For more information, visit www.talkspace.com.

    ‍For Investors:

    Neal Nagarajan

    Sloane & Company

    (301) 273-5662

    [email protected]

    For Media:

    John Kim

    SKDK

    (310) 997-5963

    [email protected]

    Forward Looking Statements

    This press release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking, including statements regarding our financial condition, anticipated financial performance, achieving profitability, business strategy and plans, market opportunity and expansion and objectives of our management for future operations. These forward-looking statements generally are identified by the words "anticipate," "believe," "contemplate," "continue," "could," "estimate," "expect," "forecast", "future", "intend," "may," "might", "opportunity", "plan," "possible", "potential," "predict," "project," "should," "strategy", "strive", "target," "will," or "would", the negative of these words or other similar terms or expressions. The absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many important factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to factors and the other risks and uncertainties described under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2022 filed with the Securities and Exchange Commission ("SEC") on March 10, 2023, and our other documents filed from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and we assume no obligation and do not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise unless required to do so under applicable law. We do not give any assurance that we will achieve our expectations.



    Talkspace, Inc.

    Condensed Consolidated Statements of Operations

    Unaudited
     
     Three Months Ended

    September 30,
       Nine Months Ended

    September 30,
      
     2023 2022 % Change 2023 2022 % Change
    (in thousands, except percentages, share and per share data)           
    Revenue:           
    Payor revenue$22,112 $9,513 132.4 $55,462 $25,503 117.5
    DTE revenue8,002 7,280 9.9 24,717 19,626 25.9
    Total B2B revenue30,114 16,793 79.3 80,179 45,129 77.7
    Consumer revenue8,532 12,539 (32.0) 27,448 44,197 (37.9)
    Total revenue38,646 29,332 31.8 107,627 89,326 20.5
    Cost of revenues19,797 14,737 34.3 54,218 45,163 20.0
    Gross profit18,849 14,595 29.1 53,409 44,163 20.9
    Operating expenses:           
    Research and development, net4,180 6,073 (31.2) 13,704 16,869 (18.8)
    Clinical operations, net1,405 2,387 (41.1) 4,681 6,257 (25.2)
    Sales and marketing13,184 18,511 (28.8) 39,698 60,098 (33.9)
    General and administrative5,259 7,475 (29.6) 15,952 23,066 (30.8)
    Total operating expenses24,028 34,446 (30.2) 74,035 106,290 (30.3)
    Operating loss(5,179) (19,851) 73.9 (20,626) (62,127) 66.8
    Financial (income), net(779) (1,885) (58.7) (2,915) (889) 227.9
    Loss before taxes on income(4,400) (17,966) 75.5 (17,711) (61,238) 71.1
    Taxes on income14 17 (17.6) 165 127 29.9
    Net loss$(4,414) $(17,983) 75.5 $(17,876) $(61,365) 70.9
    Net loss per share:           
    Basic and Diluted$(0.03) $(0.11) 72.7 $(0.11) $(0.39) 71.8
    Weighted average number of common shares:           
    Basic and Diluted166,570,673 158,330,684   164,215,802 156,056,900  



    Talkspace, Inc.

    Condensed Consolidated Balance Sheets
     
     September 30, 2023  December 31, 2022 
    (in thousands)(Unaudited)    
    ASSETS     
    CURRENT ASSETS:     
    Cash and cash equivalents$125,332  $138,545 
    Accounts receivable 7,972   9,640 
    Other current assets 4,413   4,372 
    Total current assets 137,717   152,557 
    Property and equipment, net 272   677 
    Intangible assets, net 1,971   2,529 
    Other assets 388   491 
    Total assets$140,348  $156,254 
    LIABILITIES AND STOCKHOLDERS' EQUITY     
    CURRENT LIABILITIES:     
    Accounts payable$6,512  $6,461 
    Deferred revenues 3,622   4,355 
    Accrued expenses and other current liabilities 10,717   16,502 
    Total current liabilities 20,851   27,318 
    Warrant liabilities 1,586   939 
    Other liabilities 190   461 
    Total liabilities 22,627   28,718 
    STOCKHOLDERS' EQUITY:     
    Common stock 16   16 
    Additional paid-in capital 386,783   378,722 
    Accumulated deficit (269,078)  (251,202)
    Total stockholders' equity 117,721   127,536 
    Total liabilities and stockholders' equity$140,348  $156,254 



    Talkspace, Inc.

    Condensed Consolidated Statements of Cash Flows

    Unaudited
     
      
     Nine Months Ended

    September 30,
     
     2023  2022 
    (in thousands)     
    Cash flows from operating activities:     
    Net loss$(17,876) $(61,365)
    Adjustments to reconcile net loss to net cash used in operating activities:     
    Depreciation and amortization 913   1,006 
    Stock-based compensation 6,401   9,386 
    Remeasurement of warrant liabilities 647   (421)
    Decrease (increase) in accounts receivable 1,668   (3,180)
    (Increase) decrease in other current assets (41)  4,848 
    Increase in accounts payable 51   2,931 
    Decrease in deferred revenues (733)  (1,728)
    (Decrease) increase in accrued expenses and other current liabilities (5,785)  1,465 
    Other (108)  202 
    Net cash used in operating activities (14,863)  (46,856)
    Cash flows from investing activities:     
    Purchase of property and equipment (20)  (254)
    Proceeds from sale of property and equipment 10   — 
    Net cash used in investing activities (10)  (254)
    Cash flows from financing activities:     
    Proceeds from exercise of stock options 2,059   2,696 
    Payments for employee taxes withheld related to vested stock-based awards (399)  (558)
    Payments for reverse capitalization, net of transaction costs —   (645)
    Net cash provided by financing activities 1,660   1,493 
    Net decrease in cash and cash equivalents (13,213)  (45,617)
    Cash and cash equivalents at the beginning of the period 138,545   198,256 
    Cash and cash equivalents at the end of the period$125,332  $152,639 



    Non-GAAP Financial Measures

    In addition to our financial results determined in accordance with GAAP, we believe adjusted EBITDA, a non-GAAP measure, is useful in evaluating our operating performance, and our management uses it as a key performance measure to assess our operating performance. Because adjusted EBITDA facilitates internal comparisons of our historical operating performance on a more consistent basis, we use this measure for business planning purposes and in evaluating acquisition opportunities. We also use adjusted EBITDA to evaluate our ongoing operations and for internal planning and forecasting purposes. We believe that this non-GAAP financial measure, when taken together with the corresponding GAAP financial measures, provides meaningful supplemental information regarding our performance by excluding certain items that may not be indicative of our business, results of operations or outlook. We believe that the use of adjusted EBITDA is helpful to our investors as it is a metric used by management in assessing the health of our business and our operating performance. However, non-GAAP financial information is presented for supplemental informational purposes only, has limitations as an analytical tool and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP.

    Some of the limitations of adjusted EBITDA include (i) adjusted EBITDA does not necessarily reflect capital commitments to be paid in the future and (ii) although depreciation and amortization are non-cash charges, the underlying assets may need to be replaced and adjusted EBITDA does not reflect these requirements. In evaluating adjusted EBITDA, you should be aware that in the future we will incur expenses similar to the adjustments described herein. Our presentation of adjusted EBITDA should not be construed as an inference that our future results will be unaffected by these expenses or any unusual or non-recurring items. Our adjusted EBITDA may not be comparable to similarly titled measures of other companies because they may not calculate adjusted EBITDA in the same manner as we calculate the measure, limiting its usefulness as a comparative measure. Adjusted EBITDA should not be considered as an alternative to loss before income taxes, net loss, loss per share, or any other performance measures derived in accordance with U.S. GAAP. When evaluating our performance, you should consider adjusted EBITDA alongside other financial performance measures, including our net loss and other GAAP results.

    A reconciliation is provided below for adjusted EBITDA to net loss, the most directly comparable financial measure stated in accordance with GAAP. Investors are encouraged to review our financial statements prepared in accordance with GAAP and the reconciliation of our non-GAAP financial measure to its most directly comparable GAAP financial measure, and not to rely on any single financial measure to evaluate our business. We do not provide a forward-looking reconciliation Adjusted EBITDA guidance as the amount and significance of the reconciling items required to develop meaningful comparable GAAP financial measures cannot be estimated at this time without unreasonable efforts. These reconciling items could be meaningful.

    Adjusted EBITDA

    We calculate adjusted EBITDA as net loss adjusted to exclude (i) depreciation and amortization, (ii) interest and other expenses (income), net, (iii) tax benefit and expense, (iv) stock-based compensation expense, and (v) certain non-recurring expenses, where applicable.



    Talkspace, Inc.

    Reconciliation of Non-GAAP Results to GAAP Results
     
      
     Three Months Ended

    September 30,
      Nine Months Ended

    September 30,
     
    Unaudited2023  2022  2023  2022 
    (in thousands)           
    Net loss$(4,414) $(17,983) $(17,876) $(61,365)
    Add:           
    Depreciation and amortization 305   309   913   1,006 
    Financial (income), net(1) (779)  (1,885)  (2,915)  (889)
    Taxes on income 14   17   165   127 
    Stock-based compensation 1,969   3,179   6,401   9,386 
    Non-recurring expenses(2) 105   900   89   900 
    Adjusted EBITDA$(2,800) $(15,463) $(13,223) $(50,835)
     
    (1) For the three months ended September 30, 2023, financial (income), net, primarily consisted of $1.6 million of interest income from our money market accounts partially offset by $0.8 million in losses resulting from the remeasurement of warrant liabilities. For the nine months ended September 30, 2023, financial (income), net, primarily consisted of $3.7 million of interest income from our money market accounts partially offset by $0.6 million in losses resulting from the remeasurement of warrant liabilities. For the three and nine months ended September 30, 2022, financial (income) net, primarily consisted of $1.6 million and $0.4 million, respectively, in gains resulting from the remeasurement of warrant liabilities.



    (2) For the three and nine months ended September 30, 2023, non-recurring expenses primarily consisted of $0.1 million in losses resulting from the disposition of fixed assets. For the three and nine months ended September 30, 2022, non-recurring expenses consisted of $0.6 million in legal fees and $0.3 million in general and administrative expenses.





    Primary Logo

    Get the next $TALK alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $TALK

    DatePrice TargetRatingAnalyst
    12/9/2025$3.50Equal Weight
    Barclays
    10/31/2025$5.00Hold → Buy
    Needham
    4/3/2025$5.00Buy
    Canaccord Genuity
    12/9/2024$4.50Overweight
    KeyBanc Capital Markets
    12/4/2024$5.00Outperform
    Mizuho
    11/20/2024$5.00Outperform
    Northland Capital
    7/1/2024Hold
    Needham
    1/3/2024$2.50Equal Weight
    Barclays
    More analyst ratings

    $TALK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Legal Officer, Secretary Reilly John Charles was granted 20,542 shares, increasing direct ownership by 2% to 1,038,685 units (SEC Form 4)

    4 - Talkspace, Inc. (0001803901) (Issuer)

    2/4/26 8:34:35 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Chief Technology Officer Margolin Gil was granted 49,797 shares, increasing direct ownership by 22% to 272,051 units (SEC Form 4)

    4 - Talkspace, Inc. (0001803901) (Issuer)

    2/2/26 9:30:07 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Chief Marketing Officer Watson Katelyn was granted 22,409 shares, increasing direct ownership by 6% to 376,318 units (SEC Form 4)

    4 - Talkspace, Inc. (0001803901) (Issuer)

    2/2/26 9:30:04 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    $TALK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Talkspace to Report Fourth Quarter and Full Year 2025 Results and Host Conference Call

    NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Talkspace (NASDAQ:TALK),  a leading behavioral healthcare company, today announced that it will release its fourth quarter and full year 2025 results on Thursday, February 19, 2026 before market open and host a conference call to review the results at 8:30am ET. Conference Call DetailsThe conference call will be available via audio webcast at https://investors.talkspace.com/ and can also be accessed by dialing (800) 225-9448 for U.S. participants, or (203) 518-9708 for international participants, and using conference ID TALKQ425. A replay will be available shortly after the call's completion and remain available for approximately 90 days. About

    2/5/26 4:05:00 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Nearly 30% of Americans Say Mental Health Struggles Are Blocking 2026 Goals, New Talkspace Study Finds

    Leading online therapy provider Talkspace launches "Own Your Now" campaign to help Americans bridge the gap between setting New Year's resolutions and achieving them. As the nation prepares to welcome 2026, new research reveals a significant "resolution gap": while Americans are setting ambitious goals for the New Year, nearly a third (28%) admit that mental health challenges are a major barrier to their success. To address this, Talkspace today announced the launch of "Own Your Now," an integrated campaign designed to help individuals stop delaying care and take immediate action toward emotional well-being. The campaign is inspired by new Talker Research findings highlighting that whil

    12/30/25 8:00:00 AM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Talkspace to Participate in the 44th Annual J.P. Morgan Healthcare Conference

    NEW YORK, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Talkspace (NASDAQ:TALK), a leading behavioral healthcare company, today announced that Dr. Jon Cohen, Chief Executive Officer, and Ian Harris, Chief Financial Officer, will participate in the 44th Annual J.P. Morgan Healthcare Conference, being held in San Francisco, including a presentation at 7:30am PST on Thursday, January 15, 2026. A webcast link and related presentation materials will be available on Talkspace's Investor Relations Website: https://investors.talkspace.com/. About Talkspace Talkspace (NASDAQ:TALK) is a leading virtual behavioral healthcare provider committed to helping people lead healthier, happier lives through access to

    12/22/25 4:05:00 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    $TALK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Barclays initiated coverage on Talkspace with a new price target

    Barclays initiated coverage of Talkspace with a rating of Equal Weight and set a new price target of $3.50

    12/9/25 8:53:40 AM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Talkspace upgraded by Needham with a new price target

    Needham upgraded Talkspace from Hold to Buy and set a new price target of $5.00

    10/31/25 8:16:48 AM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Canaccord Genuity initiated coverage on Talkspace with a new price target

    Canaccord Genuity initiated coverage of Talkspace with a rating of Buy and set a new price target of $5.00

    4/3/25 8:18:33 AM ET
    $TALK
    Medical/Nursing Services
    Health Care

    $TALK
    SEC Filings

    View All

    $TALK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Talkspace Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Talkspace, Inc. (0001803901) (Filer)

    1/15/26 4:13:08 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    SEC Form 10-Q filed by Talkspace Inc.

    10-Q - Talkspace, Inc. (0001803901) (Filer)

    11/6/25 8:57:37 AM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Talkspace Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Talkspace, Inc. (0001803901) (Filer)

    10/30/25 8:04:16 AM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Chief Financial Officer Harris Ian Jiro bought $86,037 worth of shares (30,844 units at $2.79), increasing direct ownership by 5% to 615,015 units (SEC Form 4)

    4 - Talkspace, Inc. (0001803901) (Issuer)

    3/5/25 4:00:06 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Chief Executive Officer Cohen Jon R bought $214,500 worth of shares (75,000 units at $2.86), increasing direct ownership by 3% to 2,267,980 units (SEC Form 4)

    4 - Talkspace, Inc. (0001803901) (Issuer)

    3/3/25 9:30:03 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Chief Legal Officer, Secretary Reilly John Charles bought $10,242 worth of shares (3,600 units at $2.85), increasing direct ownership by 0.41% to 889,806 units (SEC Form 4)

    4 - Talkspace, Inc. (0001803901) (Issuer)

    2/28/25 9:55:04 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    $TALK
    Leadership Updates

    Live Leadership Updates

    View All

    Talkspace Partners With Amazon Health Services to Help Millions Discover Mental Health Benefits

    New collaboration aims to improve awareness of, and expand access to, online therapy and psychiatry services to the 150+ million people who have Talkspace as a covered benefit Talkspace (NASDAQ:TALK), a leading online behavioral health care company, today announced a partnership with Amazon Health Services to increase awareness and discoverability of its mental health care services on Amazon.com. Talkspace is the first virtual behavioral health provider to join Amazon Health Services' program to help individuals discover and enroll in their health insurance benefits at no extra cost or for a small copay. With more than 5,000 therapists and providers across 50 states, Talkspace improves acc

    9/17/24 8:00:00 AM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Talkspace and the Professional Tennis Players Association Join Forces to Support Mental Health of Athletes Year Round

    Today, Talkspace (NASDAQ:TALK), a leading online behavioral health care company, announced its partnership with the Professional Tennis Players Association (PTPA), global advocates for professional tennis players. Talkspace will serve as the PTPA's exclusive mental health technology partner, granting players, their families, and their support teams free, 24/7 access to Talkspace's self-guided therapy app, Talkspace Go, as well as discounted access to its virtual therapy offering. "Talkspace is honored to join forces with the PTPA as its exclusive mental health provider, dedicated to delivering high-quality, evidence-based support where and when players need it. This collaboration undersco

    8/28/24 9:06:00 AM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Talkspace Appoints John Mooney as Chief Product Officer

    NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Today Talkspace (NASDAQ:TALK), a leading online behavioral health care company, announced the appointment of John Mooney as its new Chief Product Officer, to lead the company's growth initiatives, product strategy and design. Through his work for startup digital health, behavioral health, and diagnostics companies, Mr. Mooney has deep domain expertise in healthcare data, building out platform capabilities and optimizing workflows. "John has spent his career driving innovation for a range of high-growth, high-performing healthcare companies," said Dr. Jon Cohen, Chief Executive Officer, Talkspace. "We look forward to his expertise leveraging dat

    6/5/24 8:00:00 AM ET
    $TALK
    Medical/Nursing Services
    Health Care

    $TALK
    Financials

    Live finance-specific insights

    View All

    Talkspace to Report Fourth Quarter and Full Year 2025 Results and Host Conference Call

    NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Talkspace (NASDAQ:TALK),  a leading behavioral healthcare company, today announced that it will release its fourth quarter and full year 2025 results on Thursday, February 19, 2026 before market open and host a conference call to review the results at 8:30am ET. Conference Call DetailsThe conference call will be available via audio webcast at https://investors.talkspace.com/ and can also be accessed by dialing (800) 225-9448 for U.S. participants, or (203) 518-9708 for international participants, and using conference ID TALKQ425. A replay will be available shortly after the call's completion and remain available for approximately 90 days. About

    2/5/26 4:05:00 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Talkspace Announces Third Quarter 2025 Results

    3Q 2025 Total revenue grew 25% year-over-year to $59.4 million driven by 42% year-over-year growth in Payor revenue 3Q 2025 Net income of $3.3 million and adjusted EBITDA¹ of $5.0 million 3Q 2025 Share repurchases of $8.8 million NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Talkspace, Inc. ("Talkspace" or the "Company") (NASDAQ:TALK), today reported third quarter 2025 financial results.   Three Months EndedSeptember 30,  Nine Months EndedSeptember 30,   2025  2024  2025  2024 Unaudited Results  % Variance from Prior Year  Results  % Variance from Prior Year (In thousands unless otherwise noted)            Number of completed Payor sessions during the period  432.2   37%  1,167.3   30%Num

    10/30/25 8:00:00 AM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Talkspace to Report Third Quarter 2025 Results and Host Conference Call

    NEW YORK, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Talkspace (NASDAQ:TALK), a leading online behavioral health care company, today announced that it will release its third quarter 2025 results on Thursday, October 30, 2025 before market open and host a conference call to review the results at 8:30am ET. Conference Call DetailsThe conference call will be available via audio webcast at https://investors.talkspace.com/ and can also be accessed by dialing (888) 596-4144 for U.S. participants, or (646) 968-2525 for international participants, and using conference ID 9108029. A replay will be available shortly after the call's completion and remain available for approximately 90 days. About Talkspace

    10/14/25 8:00:00 AM ET
    $TALK
    Medical/Nursing Services
    Health Care

    $TALK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Talkspace Inc. (Amendment)

    SC 13G/A - Talkspace, Inc. (0001803901) (Subject)

    2/14/24 4:24:23 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G/A filed by Talkspace Inc. (Amendment)

    SC 13G/A - Talkspace, Inc. (0001803901) (Subject)

    2/9/24 7:24:33 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    SEC Form SC 13D/A filed by Talkspace Inc. (Amendment)

    SC 13D/A - Talkspace, Inc. (0001803901) (Subject)

    10/5/23 6:41:35 PM ET
    $TALK
    Medical/Nursing Services
    Health Care